Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
If you owned shares of
Novavax (NASDAQ:NVAX) at the beginning of 2020, you re probably a happy camper right now. Its shares have skyrocketed more than 3,000%. An initial investment of $10,000 would have turned into close to $325,000.
Novavax still holds the potential to make investors who buy the stock now very wealthy. But could this biotech stock even be a millionaire-maker?
Image source: Getty Images.